Answers are grounded in this paper and cite their sources.
It has been shown in nine asthmatic patients that practolol, a selective cardiac beta-adrenergic antagonist, successfully blocks the unwanted tachycardia and palpitation following isoprenaline inhalation without hindering the beneficial bronchodilator action of the drug. Practolol is a useful adjunct to bronchodilator therapy in the management of bronchial asthma.
No takes yet. Share an insight, caveat, or question.
Powles et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: